Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is an experimental small molecule belonging to the class of indole-containing organic compounds. Its structure features a pyrimidine core substituted with a chloro group and an indole moiety, linked via an amino group to a piperidine carboxamide. The molecular formula is C20H23ClN6O, and it has been cataloged in chemical databases such as DrugBank (DB08005), ChemSpider, and PubChem. There is no evidence that this compound has reached clinical development or approval for any therapeutic indication, nor are there published data on its mechanism of action or biological targets. It appears to be primarily used as a research chemical or screening tool in drug discovery efforts.[1][2][8]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide.